Evidence map›Paper›PMID 26014388›Full record

ArticleScientific reports2015

Exercise intolerance and developmental delay associated with a novel mitochondrial ND5 mutation.

Hezhi Fang, Hao Shi, Xiyuan Li, Dayan Sun, Fengjie Li, Bin Li, Yuan Ding, Yanyan Ma, Yupeng Liu, Yao Zhang and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Mitochondrial tRNAHuman mutation · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Hezhi FangKey Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, College of Laboratory Medicine and Life sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Hao ShiKey Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, College of Laboratory Medicine and Life sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Xiyuan LiDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Dayan SunKey Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, College of Laboratory Medicine and Life sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Fengjie LiKey Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, College of Laboratory Medicine and Life sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Bin LiKey Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, College of Laboratory Medicine and Life sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Yuan DingDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Yanyan MaDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Yupeng LiuDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Yao ZhangDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Lijun ShenKey Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, College of Laboratory Medicine and Life sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Yidong BaiDepartment of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Yanling YangDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Jianxin LuKey Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, College of Laboratory Medicine and Life sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
Wenzhou Medical University · CNPeking University First Hospital · CNPeking University · CNThe University of Texas Health Science Center at San Antonio · US

Funding

Regulation of mitochondrial respiratory complex I dynamicsR01GM109434 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BAI, YIDONG · 2014 to 2017
$1.3M
NIGMS NIH HHS R01 GM109434
6 · The paper itself

Abstract

The aim of this study was to evaluate the contribution of mitochondrial DNA (mtDNA) mutations in oxidative phosphorylation (OXPHOS) deficiency. The complete mitochondrial genomes of 41 families with OXPHOS deficiency were screened for mutations. Mitochondrial functional analysis was then performed in primary and cybrid cells containing candidate mutations identified during the screening. A novel mitochondrial NADH dehydrogenase 5 (ND5) m.12955A > G mutation was identified in a patient with exercise intolerance and developmental delay. A biochemical analysis revealed deficiencies in the activity of complex I (NADH:quinone oxidoreductase) and IV (cytochrome c oxidase) of this patient. Defects in complexes I and IV were confirmed in transmitochondrial cybrid cells containing the m.12955A > G mutation, suggesting that this mutation impairs complex I assembly, resulting in reduced stability of complex IV. Further functional investigations revealed that mitochondria with the m.12955A > G mutation exhibited lower OXPHOS coupling respiration and adenosine triphosphate (ATP) generation. In addition, the cytotoxic effects, determined as reactive oxygen species (ROS) and lactate levels in the present study, increased in the cells carrying a higher m.12955A > G mutant load. In conclusion, we identified m.12955A > G as a mitochondrial disease-related mutation. Therefore, screening of m.12955A > G is advised for the diagnosis of patients with mitochondrial disease.

Indexed as

Adenosine TriphosphateBase SequenceBrainChildElectron Transport Chain Complex ProteinsElectron Transport Complex IExerciseFemaleHumansMagnetic Resonance ImagingMitochondriaMitochondrial DiseasesMitochondrial ProteinsMutation, MissenseOxidative PhosphorylationOxygen ConsumptionAdenosine TriphosphateElectron Transport Chain Complex ProteinsElectron Transport Complex IMitochondrial ProteinsMT-ND5 protein, humanReactive Oxygen Species

Identifiers

PMID26014388
PMCPMC4444849
OpenAlexW1896432858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.